During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization. The post Lawmakers Grill Health Insurance CEOs: 4 Key Takeaways appeared first on MedCity News.
Bessemer Venture Partners predicted that 2026 will be a breakout year for healthcare AI, driven by increased adoption of clinical AI, a new class of AI-first value-based care companies, and the emerging digital health category of data infrastructure tools. The post How Bessemer Sees 2026 Shaping Up as Healthcare AI’s Breakout Year appeared first on…
In 2026, the company plans to open 15 de novo clinics – including several in new markets such as Chicago, Milwaukee and Dallas
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Bristol Myers Squibb is paying $50 million to begin a collaboration with Janux Therapeutics, a company that develops T cell engagers that activate specifically at the site of the tumor. It’s the second big pharma alliance for Janux, which has been working with Merck. The post BMS Tries Again With T Cell Engagers, Turning to…
Starting in May of last year, HHS Secretary Kennedy and the CDC/ACIP began to make changes to the federal vaccine schedule for children, culminating in an announcement on January 5 of this year with the most wide-ranging changes to date. This policy brief tracks the number of states that have announced they are no longer…
[Sponsored] High-quality surgical instruments are nonnegotiable in modern healthcare, but escalating costs are forcing leaders and clinicians to rethink how and where they source them. The post Where to Find High-Quality Surgical Instruments at Budget-Friendly Prices appeared first on MedCity News.
That is the topic of an Evidence Base article out today titled “Reflecting on 2025, looking to 2026: Experts outline what to expect for drug pricing and market access“. In the article, a variety of experts reflect on how 2025 reshaped the global drug pricing and market access landscape as well as predict what to…
Organizations can take steps now, in the early months of the program, to position themselves for success by evaluating past performance, identifying opportunities for improvement, and implementing episode-driven clinical and operational workflows. The post TEAM is Here, and Hospitals Are Running Out of Time to Prepare appeared first on MedCity News.
This budget summary provides an analysis of global health funding amounts provided in the FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) conference bill and accompanying report.